Literature DB >> 10383372

Limitations of cytomegalovirus testing.

J Harmenberg, M Brytting.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10383372      PMCID: PMC89316     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  7 in total

1.  Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals.

Authors:  W L Drew; R Miner; E Saleh
Journal:  Clin Diagn Virol       Date:  1993-08

2.  Pharmacokinetics and absolute bioavailability of oral foscarnet in human immunodeficiency virus-seropositive patients.

Authors:  F H Noormohamed; M S Youle; C J Higgs; S Martin-Munley; B G Gazzard; A F Lant
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

3.  Cytomegalovirus resistance to antiviral therapies.

Authors:  W L Drew
Journal:  Am J Health Syst Pharm       Date:  1996-04-15       Impact factor: 2.637

4.  High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes.

Authors:  I L Smith; J M Cherrington; R E Jiles; M D Fuller; W R Freeman; S A Spector
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

5.  Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.

Authors:  D A Jabs; C Enger; M Forman; J P Dunn
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.

Authors:  D A Jabs; C Enger; J P Dunn; M Forman
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

7.  Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group.

Authors:  D A Jabs; J P Dunn; C Enger; M Forman; N Bressler; P Charache
Journal:  Arch Ophthalmol       Date:  1996-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.